Avid Bioservices Inc (CDMO)

[biopharm]

MRI images critically important so Fujifilm, we welcome you aboard with any offers you may have for investments as well : )

... Fujifilm Diosynth Biotechnologies ...

Are we being tipped to whom one of our initial, future partners may be?

http://www.fujifilmdiosynth.com

...and I bet Roger Lias knows liposomes contain Phosphatidylserine
https://www.ncbi.nlm.nih.gov/pubmed/20176740

____________________

September 11, 2017
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid Bioservices
...
...
Throughout his career, Dr. Lias has held senior management positions at several leading CDMOs including Cytovance Biologics, KBI BioPharma, Diosynth RTP (formerly Covance Biotechnology Services) and Lonza Biologics. At each of these companies, he was primarily charged with overseeing commercial operations, including growing and diversifying their respective client bases. During this time, Dr. Lias' achievements ranged from building start-up Cytovance's contract process development and biopharmaceutical cGMP production business, to increasing revenues at Diosynth from $16 million to $120 million over a four-year period. Additionally, he has built a reputation as a highly regarded CDMO industry advocate who has contributed to the acceptance and growth of the biologics contract manufacturing market. Dr. Lias earned his Ph.D. from Clare College at the University of Cambridge in the United Kingdom.
..
..
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=1039872

-------

Cristina Brinkmann ex-Xencor and I am trying to see more clearly like those new MRI flipped PS Targeting may be doing....but since new Roger Lias President has Diosynth

https://www.linkedin.com/in/beth-jones-a1540a14

...as usual, lots of puzzle pieces to place and analyze and it is more difficult a bit with research gate locked down to see who those new followers are to key researchers of PS Targeting but it only means PS Targeting may be just as important as ever before